Journal of Diabetes Research / 2015 / Article / Tab 4

Research Article

Liraglutide, a Glucagon-Like Peptide-1 Analog, Increased Insulin Sensitivity Assessed by Hyperinsulinemic-Euglycemic Clamp Examination in Patients with Uncontrolled Type 2 Diabetes Mellitus

Table 4

Correlation between changes in glucose infusion rate at euglycemic-hyperinsulinemic clamp and clinical variables in patients treated with liraglutide.


Changes in body mass index−0.0860.760
Changes in hemoglobin A1c (%)−0.1010.710
Changes in fasting blood glucose (mg/dL)−0.1650.540
Changes in fasting blood insulin (µU/mL)0.1280.650
Changes in fasting blood CPR (ng/mL)−0.1540.583
Changes in postprandial blood glucose (mg/dL)−0.3830.143
Changes in postprandial blood insulin (µU/mL)0.0670.819
Changes in postprandial blood CPR (ng/mL)−0.2930.309

CPR: C-peptide radioimmunoreactivity.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.